Evexia Lifecare

how big is Evexia Lifecare?

As of Jun 06, Evexia Lifecare Ltd has a market capitalization of 469.33 Cr, classifying it as a Micro Cap company, with net sales of 93.25 Cr and a net profit of 1.36 Cr for the latest four quarters. The shareholder's funds are valued at 129.40 Cr, and total assets amount to 883.00 Cr as of Mar'24.

Market Cap: As of Jun 06, Evexia Lifecare Ltd has a market capitalization of 469.33 Cr, which classifies it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Evexia Lifecare Ltd reported net sales of 93.25 Cr and a net profit of 1.36 Cr. This data is consolidated.<BR><BR>Balance Sheet Snapshot: This is consolidated data for the latest annual period ending in Mar'24. The shareholder's funds are valued at 129.40 Cr, and the total assets amount to 883.00 Cr.

Who are in the management team of Evexia Lifecare?

As of March 2022, the management team of Evexia Lifecare includes Jayesh R Thakkar (Chairman & Managing Director), Kartik Mistry, Chandresh Kumar Vishnubhai Kahar, Hasmukhbhai Thakkar, Naresh Arvindbhai Patel, Payal Gajjar (all Independent Directors), Parul Samalia (Company Secretary & Compliance Officer), and Parth Patel (Additional Director). They oversee the company's operations and governance.

As of March 2022, the management team of Evexia Lifecare includes the following individuals:<BR><BR>1. Jayesh R Thakkar - Chairman & Managing Director<BR>2. Kartik Mistry - Independent Director<BR>3. Chandresh Kumar Vishnubhai Kahar - Independent Director<BR>4. Hasmukhbhai Thakkar - Independent Director<BR>5. Naresh Arvindbhai Patel - Independent Director<BR>6. Payal Gajjar - Independent Director<BR>7. Parul Samalia - Company Secretary & Compliance Officer<BR>8. Parth Patel - Additional Director<BR><BR>This team is responsible for overseeing the company's operations and governance.

What does Evexia Lifecare do?

Evexia Lifecare Ltd operates in the edible oil industry as a micro-cap company, with a market cap of Rs 469 Cr and reported net sales of 24 Cr and net profit of 0 Cr for the quarter ending March 2025. The company was renamed from Jal Hi Power Petrochem Limited in December 2020.

Overview:<BR>Evexia Lifecare Ltd operates in the edible oil industry and is categorized as a micro-cap company.<BR><BR>History:<BR>The company was originally incorporated as Jal Hi Power Petrochem Limited in 1990, underwent several name changes, and was most recently renamed Evexia Lifecare Limited on December 01, 2020. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 24 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 0 Cr (Quarterly Results - Mar 2025)<BR>- Market-cap: Rs 469 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 344.00<BR>- Industry P/E: 20<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.87<BR>- Return on Equity: 0.31%<BR>- Price to Book: 1.07<BR><BR>Contact Details:<BR>- Address: Village - Tundao, Tal Savli Vadodara Gujarat : 391775<BR>- Phone: 91-265-2362200/2361100<BR>- Email: kavitindustrieslimited@gmail.com<BR>- Website: http://www.evexialifecare.com

What is the bonus history of the Evexia Lifecare?

Evexia Lifecare issued a bonus on October 23, 2015, in a 1:3 ratio, granting one additional share for every three shares held, with the record date set for October 26, 2015.

Evexia Lifecare has a bonus history that includes a notable issue on October 23, 2015. The company announced a bonus in a ratio of 1:3, meaning that for every three shares held, shareholders received one additional share. The record date for this bonus was October 26, 2015, which is when the eligibility for receiving the bonus shares was determined. If you have any more questions about Evexia Lifecare or need further details, feel free to ask!

Has Evexia Lifecare declared dividend?

No Dividend History Available

Who are the peers of the Evexia Lifecare?

Evexia Lifecare's peers include Marico, Patanjali Foods, AWL Agri Business, Gokul Agro, and others. While Marico shows excellent management risk and capital structure, Evexia Lifecare has below-average growth and capital structure, with a 1-year return of 1.23%.

Peers: The peers of Evexia Lifecare are Marico, Patanjali Foods, AWL Agri Busine., Gokul Agro, Sundrop Brands, Gokul Refoils, Shri Venkatesh, Ajanta Soya, Vijay Solvex, and M K Proteins.<BR><BR>Quality Snapshot: Excellent management risk is observed at Marico, while Average management risk is found at Patanjali Foods, Gokul Agro, Sundrop Brands, Shri Venkatesh, Ajanta Soya, and Vijay Solvex, and the rest. Below Average management risk is seen at AWL Agri Busine., Gokul Refoils, and M K Proteins. Growth is Excellent at Patanjali Foods and Gokul Agro, Good at AWL Agri Busine. and the rest, while Below Average growth is noted at Marico, Sundrop Brands, Gokul Refoils, Evexia Lifecare, Shri Venkatesh, Ajanta Soya, Vijay Solvex, and M K Proteins. Capital Structure is Excellent at Marico and Ajanta Soya, Good at Patanjali Foods, AWL Agri Busine., Gokul Agro, and Vijay Solvex, while Below Average is observed at Gokul Refoils, Evexia Lifecare, Shri Venkatesh, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Shri Venkatesh at 93.70%, while the lowest is AWL Agri Busine. at -27.15%. Evexia Lifecare's 1-year return is 1.23%, which is significantly lower than both extremes. Additionally, Gokul Refoils, Evexia Lifecare, AWL Agri Busine., and M K Proteins have negative six-month returns.

What is the technical trend for Evexia Lifecare?

As of June 2, 2025, Evexia Lifecare's trend has shifted to bearish with moderate strength, supported by bearish indicators from moving averages and Bollinger Bands, despite mixed signals from the KST and MACD.

As of 2 June 2025, the technical trend for Evexia Lifecare has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. The weekly MACD is mildly bullish, but the monthly MACD is bearish, indicating a divergence in momentum. Both the weekly and monthly Bollinger Bands are bearish, reinforcing the negative trend. Daily moving averages are also bearish, suggesting continued downward pressure. The KST shows mixed signals with a mildly bullish weekly reading and a mildly bearish monthly reading. Overall, the lack of clear signals from the RSI and Dow Theory indicates a weak trend, further supporting the bearish outlook.

Who are the top shareholders of the Evexia Lifecare?

The top shareholders of Evexia Lifecare include Aio Growth Capital Fund Spc at 12.17%, Raghuvir International at 1.55%, and individual investors holding 36.68%. There is minimal mutual fund and foreign institutional investor involvement, with no pledged promoter holdings.

The top shareholders of Evexia Lifecare include a mix of individual and institutional investors. The largest public shareholder is Aio Growth Capital Fund Spc, holding 12.17%. Among the promoters, Raghuvir International has the highest holding at 1.55%. Additionally, individual investors collectively hold a significant portion, accounting for 36.68% of the shares. The company also has some mutual fund involvement, with three schemes holding a total of 0.02%, and one foreign institutional investor (FII) holding 0.16%. Notably, there are no pledged promoter holdings.

Is Evexia Lifecare overvalued or undervalued?

As of October 23, 2025, Evexia Lifecare is considered overvalued with a high PE ratio of 212.41 and an EV to EBITDA ratio of 206.57, significantly contrasting with its peers, and has underperformed the market with a year-to-date decline of 42.61%.

As of 23 October 2025, Evexia Lifecare's valuation grade has moved from very expensive to expensive, indicating a slight improvement in its perceived value. However, based on the current financial metrics, the company remains overvalued. The PE ratio stands at an exceptionally high 212.41, while the EV to EBITDA ratio is also elevated at 206.57, suggesting that the market is pricing in significant growth expectations that may not be justified by the company's performance.<BR><BR>In comparison to its peers, Evexia Lifecare's ratios starkly contrast with those of Gulf Oil Lubricants and Veedol Corporation, which have PE ratios of 16.16 and 16.62, respectively, and EV to EBITDA ratios of 10.99 and 14.69. These peers are classified as very attractive, highlighting the disparity in valuation. Furthermore, Evexia's return metrics are concerning, with a year-to-date decline of 42.61%, significantly underperforming the Sensex's 8.21% gain during the same period. This underperformance reinforces the view that Evexia Lifecare is overvalued in the current market environment.

How has been the historical performance of Evexia Lifecare?

Evexia Lifecare's historical performance shows significant sales growth from 56.29 Cr in Mar'24 to 110.48 Cr in Mar'25, despite previous declines. While operating profit improved, profitability metrics decreased, and total liabilities rose, indicating a mixed financial outlook.

Answer:<BR>The historical performance of Evexia Lifecare shows significant fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Evexia Lifecare's net sales increased from 56.29 Cr in Mar'24 to 110.48 Cr in Mar'25, marking a substantial growth. However, net sales had previously declined from 69.55 Cr in Mar'23 to 56.29 Cr in Mar'24. The total operating income followed a similar trend, rising to 110.48 Cr in Mar'25 from 56.29 Cr in Mar'24, after a dip in the preceding years. The total expenditure, excluding depreciation, also increased to 106.40 Cr in Mar'25 from 54.31 Cr in Mar'24, reflecting higher costs associated with the increased sales. Operating profit (PBDIT) improved to 4.22 Cr in Mar'25 from 2.85 Cr in Mar'24, indicating better operational efficiency. Profit before tax showed a slight decrease to 1.44 Cr in Mar'25 from 1.93 Cr in Mar'24, while profit after tax also declined to 0.93 Cr in Mar'25 from 1.38 Cr in Mar'24. The company's total liabilities rose to 883.00 Cr in Mar'24 from 847.50 Cr in Mar'23, with long-term borrowings remaining significant at 676.64 Cr in Mar'24. Cash flow from operating activities improved to 17.00 Cr in Mar'24, contrasting with a negative cash flow in the previous year, while cash flow from investing activities saw a substantial outflow of -17.00 Cr in Mar'24. Overall, Evexia Lifecare's financial performance reflects a recovery in sales and operational profit, despite challenges in profitability and increasing liabilities.

Are Evexia Lifecare Ltd latest results good or bad?

Evexia Lifecare Ltd's latest results are concerning, showing a 21.62% decline in net profit and a significant drop in operating margins, despite a year-on-year revenue growth of 16.31%. Overall, the financial performance indicates serious challenges in operational efficiency and profitability.

Evexia Lifecare Ltd's latest results present a mixed but largely concerning picture. For the quarter ending December 2025, the company reported a net profit of ₹0.29 crores, which is a significant decline of 21.62% compared to the previous quarter. While there was a year-on-year revenue growth of 16.31%, the sequential revenue showed a slight decline of 1.90%, indicating some challenges in maintaining momentum.<BR><BR>The operating margin has also seen a dramatic drop, falling to just 0.99% from 4.84% in the previous quarter. This sharp decline in profitability metrics suggests significant operational stress within the company, particularly in its core edible oil business. The profit after tax (PAT) margin also contracted to 1.15%, down from 1.44% in the previous quarter.<BR><BR>Overall, while there is some positive year-on-year revenue growth, the substantial decline in net profit and operating margins raises serious concerns about the company's operational efficiency and profitability. The financial performance indicates that Evexia Lifecare is facing significant challenges, making the latest results more negative than positive.

Should I buy, sell or hold Evexia Lifecare Ltd?

Why is Evexia Lifecare Ltd falling/rising?

As of 06-May, Evexia Lifecare Ltd's stock price is rising to 1.17, reflecting a 4.46% increase, supported by a strong performance over the past week and month. Despite a year-to-date decline of 28.66% and a 56.02% drop over the past year, recent gains indicate strong investor interest.

As of 06-May, Evexia Lifecare Ltd's stock price is rising, currently at 1.17, with a change of 0.05, representing a 4.46% increase. This upward movement is supported by a strong performance over the past week, where the stock has gained 19.39%, significantly outperforming the Sensex, which only increased by 0.60%. Additionally, the stock has shown remarkable growth over the last month, with a staggering 129.41% increase compared to the Sensex's 5.20% rise.<BR><BR>The stock has been on a consecutive gain streak for the last 21 days, accumulating a total return of 138.78% during this period. This consistent upward trend indicates strong investor interest and confidence in the stock. Furthermore, the stock's performance today has outperformed its sector by 2%, contributing to its rising price.<BR><BR>However, it is important to note that while the stock is currently rising, it has experienced a decline of 28.66% year-to-date and a significant drop of 56.02% over the past year. Despite these longer-term declines, the recent short-term performance has been positive, which is likely driving the current rise in stock price.

Which are the latest news on Evexia Lifecare?

When is the next results date for Evexia Lifecare Ltd?

The next results date for Evexia Lifecare Ltd is 09 May 2026.

The next results date for Evexia Lifecare Ltd is scheduled for 09 May 2026.